Surgical and Nonsurgical Treatment of Pediatric Monteggia Fractures: A Systematic Review

儿童蒙特吉亚骨折的手术和非手术治疗:系统评价

阅读:1

Abstract

BACKGROUND: There remains controversy surrounding the treatment of pediatric Monteggia fractures. This systematic review examines the existing literature with the aim to elucidate optimal management strategies. METHODS: A systematic review using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines was conducted. All data collection was completed by May 27, 2024. RESULTS: Thirteen studies were included, with three evaluating only surgical techniques, two evaluating only conservative techniques, and eight evaluating surgical versus conservative treatment. The mean Quality Appraisal Tool rating of all the studies was 63.4%, with five level III and eight level IV studies. There were 696 cases, with an average age of 6.6 years (range: 11 months-18 years), with 375 Bado Type 1, 31 Bado Type 2, 193 Bado Type 3, and 32 Bado Type 4 fractures. Overall outcomes were generally good for both conservatively and surgically treated fractures. The most frequently reported indication for surgery was failure of conservative treatment. There was a 6.0% complication rate and a 14.6% complication rate for conservative and surgical treatment, respectively. CONCLUSIONS: Although there is still no consensus on the treatment of pediatric Monteggia fractures, both operative and nonoperative approaches result in good outcomes with expeditious treatment. KEY CONCEPTS: (1)Standardized treatment of pediatric Monteggia fractures remains elusive.(2)Whereas surgeons agree that early diagnosis and expeditious treatment are essential, it remains unclear whether an initial trial of conservative treatment or immediate surgical intervention is indicated.(3)More stable fracture patterns tend to do well with a conservative approach, and there tend to be more complications with surgery.(4)More research is necessary to determine if there is a true difference in healing outcomes between the two treatment options. LEVEL OF EVIDENCE: Level IV-therapeutic.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。